In early trading, Gilead Sciences leads Nasdaq 100 with a 1.8% increase, boasting a 36.8% gain year to date. Conversely, Strategy is the worst performer, down 2.0% and 44.4% lower for the year. PepsiCo is down 1.9%, while AstraZeneca is up 1.6% on the day. Market movements detailed in Nasdaq 100 Movers.

Read more at Nasdaq: Nasdaq 100 Movers: MSTR, GILD